Crescent Grove Advisors LLC Has $633,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Crescent Grove Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,251 shares of the healthcare conglomerate’s stock after acquiring an additional 65 shares during the period. Crescent Grove Advisors LLC’s holdings in UnitedHealth Group were worth $633,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. KFG Wealth Management LLC grew its stake in UnitedHealth Group by 8.6% in the 4th quarter. KFG Wealth Management LLC now owns 2,036 shares of the healthcare conglomerate’s stock valued at $1,030,000 after buying an additional 162 shares during the last quarter. Jamison Private Wealth Management Inc. boosted its stake in UnitedHealth Group by 11.9% during the 4th quarter. Jamison Private Wealth Management Inc. now owns 1,371 shares of the healthcare conglomerate’s stock valued at $693,000 after purchasing an additional 146 shares during the period. Blue Square Asset Management LLC increased its position in UnitedHealth Group by 2.5% in the 4th quarter. Blue Square Asset Management LLC now owns 5,245 shares of the healthcare conglomerate’s stock worth $2,653,000 after buying an additional 127 shares during the period. Archford Capital Strategies LLC grew its stake in shares of UnitedHealth Group by 1.0% in the fourth quarter. Archford Capital Strategies LLC now owns 8,939 shares of the healthcare conglomerate’s stock worth $4,522,000 after acquiring an additional 86 shares during the last quarter. Finally, Duncan Williams Asset Management LLC raised its stake in UnitedHealth Group by 5.7% during the 4th quarter. Duncan Williams Asset Management LLC now owns 2,721 shares of the healthcare conglomerate’s stock valued at $1,377,000 after purchasing an additional 147 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $532.26 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a market cap of $489.83 billion, a P/E ratio of 34.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The business’s fifty day moving average is $541.04 and its 200-day moving average is $563.84.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. UnitedHealth Group’s payout ratio is 54.19%.

Analyst Ratings Changes

UNH has been the topic of several research reports. TD Cowen boosted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $627.74.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.